Experian Health's State of Claims survey finds 40% of providers have at least 10% of their claims denied, and only 30% recover most of that lost revenue.
|Articles|March 23, 2022
Coronavirus Omicron variant, vaccine, and case numbers in the United States: March 23, 2022
Author(s)Logan Lutton
How many novel coronavirus (COVID-19) cases were announced today?
Advertisement
The
Here’s the latest data, updated on March 23:
Positive tests: 79,803,443
Patient deaths: 973,213
Total vaccine doses distributed: 698,418,375
Patients who’ve received the second dose: 217,110,680
% of population fully vaccinated: 65.4%
% of infections tied to the Omicron Variant: 100%
Advertisement
Related to this article
CKD is growing as a global health problem, but screenings and treatments aren't reaching patients who need them.
The top news stories in medicine this week.
CMS' 2027 proposal fixes the quality list, but the roster still spins.
Payer enrollment rarely lines up with a new physician’s first day. A week-by-week plan helps practices avoid a revenue gap, handle pending claims and know when the schedule can safely open.
Clinical enthusiasm doesn't equal a purchase order, and device makers need a case that wins over both clinicians and hospital buyers early in development.
Blue Cross and Blue Shield of Texas is leaving Medicare Advantage, and several Florida systems are splitting with UnitedHealthcare. Here's what changes by state before the Dec. 7 deadline.
In three online experiments, adults who would have to pay for a procedure out of pocket were less likely to schedule it, and the anxiety the cost caused raised the pain they expected.
Advertisement
Advertisement
Trending on Medical Economics
1
Blue Cross and Blue Shield of Texas leaves Medicare Advantage as UnitedHealthcare splits with Florida health systems
2
82% of Americans back a law requiring human review of AI claim denials, survey finds
3
Medicare is still swiping left on your patients
4
Out-of-pocket costs make patients less willing to book recommended procedures, study finds
5